These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38751010)

  • 21. Antithrombotic strategies after interventional left atrial appendage closure: an update.
    Chen S; Weise FK; Chun KRJ; Schmidt B
    Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):675-678. PubMed ID: 30095350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis.
    Tsai YC; Phan K; Munkholm-Larsen S; Tian DH; La Meir M; Yan TD
    Eur J Cardiothorac Surg; 2015 May; 47(5):847-54. PubMed ID: 25064051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left atrial appendage occlusion for atrial fibrillation and bleeding diathesis.
    Kailey BS; Koa-Wing M; Sutaria N; Mott T; Sohaib A; Qureshi N; Shi C; Padam P; Howard J; Kanagaratnam P
    J Cardiovasc Electrophysiol; 2023 Dec; 34(12):2552-2562. PubMed ID: 37962263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of ablation for atrial fibrillation in combination with left atrial appendage occlusion in octogenarians.
    Zhang PP; Zhao Y; Sun J; Wang QS; Li W; Zhang R; Chen M; Mo BF; Yu Y; Feng XF; Liu B; Yu YC; Lu QF; Li YG
    Clin Cardiol; 2023 Oct; 46(10):1202-1209. PubMed ID: 37522390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of thromboembolic events after percutaneous left atrial appendage ligation in patients with atrial fibrillation: Long-term results of a multicenter study.
    Mohanty S; Gianni C; Trivedi C; Gadiyaram V; Della Rocca DG; MacDonald B; Horton R; Al-Ahmad A; Gibson DN; Price M; Krumerman AK; Palma EC; Di Biase L; Lakkireddy D; Natale A
    Heart Rhythm; 2020 Feb; 17(2):175-181. PubMed ID: 31400519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
    Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
    Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey.
    Tilz RR; Potpara T; Chen J; Dobreanu D; Larsen TB; Haugaa KH; Dagres N
    Europace; 2017 Oct; 19(10):1737-1742. PubMed ID: 29016910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left atrial thrombus in patients with atrial fibrillation and under oral anticoagulant therapy; 3-D transesophageal echocardiographic study.
    Durmaz E; Karpuz MH; Bilgehan K; Ikitimur B; Ozmen E; Ebren C; Polat F; Koca D; Tokdil KO; Kandemirli SG; Atici A; Ongen Z
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1097-1103. PubMed ID: 32140812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion.
    Ge H; Zhang C; Qiao ZQ; Hao ZY; Li Z; Gu ZC; Jiang LS; He B; Pu J
    Sci Prog; 2022; 105(3):368504221113194. PubMed ID: 35849447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis.
    Chew DS; Zhou K; Pokorney SD; Matchar DB; Vemulapalli S; Allen LA; Jackson KP; Samad Z; Patel MR; Freeman JV; Piccini JP
    Ann Intern Med; 2022 Sep; 175(9):1230-1239. PubMed ID: 35969865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial Experience With High-Risk Patients Excluded From Clinical Trials: Safety of Short-Term Anticoagulation After Left Atrial Appendage Closure Device.
    Barakat AF; Hussein AA; Saliba WI; Bassiouny M; Tarakji K; Kanj M; Jaber W; Rodriguez LL; Grimm R; Hussain MS; Russman A; Uchino K; Wisco D; Rasmussen P; Bain M; Vargo J; Zuccaro G; Gottesman D; Lindsay BD; Wazni OM
    Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27225288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale and design of a randomized clinical trial to compare two antithrombotic strategies after left atrial appendage occlusion: double antiplatelet therapy vs. apixaban (ADALA study).
    Flores-Umanzor EJ; Cepas-Guillen PL; Arzamendi D; Cruz-González I; Regueiro A; Freixa X
    J Interv Card Electrophysiol; 2020 Nov; 59(2):471-477. PubMed ID: 32986176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage Occlusion.
    Reinhardt SW; Gibson DN; Hsu JC; Kapadia SR; Yeh RW; Price MJ; Piccini JP; Nair DG; Christen T; Allocco DJ; Freeman JV
    J Am Coll Cardiol; 2024 Sep; 84(10):889-900. PubMed ID: 39197978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: Rationale and design of the OPTION randomized trial.
    Wazni OM; Boersma L; Healey JS; Mansour M; Tondo C; Phillips K; Doshi R; Jaber W; Hynes E; Allocco DJ; Reddy VY
    Am Heart J; 2022 Sep; 251():35-42. PubMed ID: 35526570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Gloekler S; Saw J; Koskinas KC; Kleinecke C; Jung W; Nietlispach F; Meier B
    Int J Cardiol; 2017 Dec; 249():234-246. PubMed ID: 28882323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation.
    Di Biase L; Callans D; Hæusler KG; Hindricks G; Al-Khalidi H; Mont L; Cosedis Nielsen J; Piccini JP; Schotten U; Kirchhof P
    Europace; 2017 Jan; 19(1):132-138. PubMed ID: 28130378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of Intraatrial Thrombi After Thoracoscopic Ablation in Absence of Heparin and Appendage Closure.
    Budera P; Osmancik P; Herman D; Talavera D; Petr R; Straka Z
    Ann Thorac Surg; 2017 Sep; 104(3):790-796. PubMed ID: 28433223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.